Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04998019 · ClinicalTrials.gov registry record · NA
PositiveLinks: mHealth for DC Cohort
A NA study of HIV/AIDS, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 682
- Enrollment target
- 13
- Study locations
NCT04998019: Completed NA study of HIV/AIDS, sponsored by George Washington University.
NCT04998019 is a NA study of HIV/AIDS that has completed, run by George Washington University. The registered enrollment target is 682 participants, below the 33,169-participant average among 61 other HIV/AIDS trials with a reported enrollment target (98% lower). The trial reports 13 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04998019, a NA study of HIV/AIDS, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 682 participants
- Enrollment target
- 13
- Study locations
Study Summary
To achieve the end of the HIV epidemic, concerted efforts will be needed to address the HIV care continuum, including improving retention in care (RIC) and viral suppression (VS) among persons with HIV (PWH). In the U.S., less than 50% of PWH are RIC and even fewer are VS. Studies have shown that these PWH have poorer clinical outcomes and are at risk of transmitting HIV to others, hence the need for innovative solutions to improve retention in care and subsequent viral suppression. Theory-based mHealth interventions have been shown to be promising in reaching these at-risk groups and improving HIV-related outcomes. PositiveLinks is a clinic-deployed mHealth platform that includes patient and provider smartphone apps, a web portal for clinic staff and providers to manage patient cohorts, an online implementation guide, and a learning management system to train and certify clinic staff. It has theory-based features including daily queries of adherence, mood, and stress, graphical feedback for self-monitoring, secure messaging with staff, appointment reminders, anonymized peer support, information resources, and document upload capability to support insurance re-enrollment. A 12-month prospective study in poorly retained PWH found that PL increased RIC and VS, with app use related to benefit as well as improved social support and stigma. PL is a promising existing mHealth tool for PWH, yet its efficacy has not been tested in a randomized trial, nor in urban populations. The investigators will test the efficacy of PositiveLinks to improve RIC and VS among a cohort of PWH in a high HIV prevalence city of Washington, DC. Participants will be identified from the DC Cohort, a longitudinal prospective cohort of PWH receiving HIV care at 15 clinics in DC. First, the investigators will conduct formative research to assess the feasibility, acceptability and usability of PositiveLinks among this urban cohort and conduct subsequent adaptations based on these findings. The invest
Primary Outcome
Viral Suppression will be the nearest viral load measurement to the 12-month study time point for the participant, +/-90 days.
Conditions Studied
Interventions
- BEHAVIORAL PositiveLinks
Study Locations (13)
District of Columbia
- MetroHealth - Washington D.C.
- Unity Medical Center - Washington D.C.
- Georgetown University - Washington D.C.
- La Clinica Del Pueblo - Washington D.C.
- Children's National Medical Center Pediatric Clinic - Washington D.C.
- Medstar Washington Hospital Center - Washington D.C.
- Washington Health Institute - Washington D.C.
- Family and Medical Counseling Service - Washington D.C.
- Whitman-Walker Health - Washington D.C.
- George Washington Medical Faculty Associates - Washington D.C.
- Howard University Hospital Adult Clinic - Washington D.C.
- Howard University Hospital Pediatric Clinic - Washington D.C.
- Veterans Affairs Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 682 participants |
| Start Date | 2022-12-12 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
What the finished NCT04998019 record still lists
NCT04998019 is an interventional study that assigns participants to a tested intervention. The registered 682 participants enrollment target is mid-sized for trials with a published cap, below the 33,169-participant average among 61 other HIV/AIDS trials with a reported enrollment target (98% lower).
The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 1 intervention - of which PositiveLinks is the first listed.
NCT04998019 lists 13 locations in 1 state (District of Columbia).
Frequently Asked Questions
What is clinical trial NCT04998019 about?
NCT04998019 is a clinical study titled "PositiveLinks: mHealth for DC Cohort". To achieve the end of the HIV epidemic, concerted efforts will be needed to address the HIV care continuum, including improving retention in care (RIC) and viral suppression (VS) among persons with HIV (PWH). In the U.S., less than 50% of PWH are RIC and even fewer are VS. Studies have shown that th...
What is the current status of trial NCT04998019?
This trial is currently completed. It is a NA study. The enrollment target is 682 participants. The study started on 2022-12-12. Estimated completion is 2025-06-30.
What conditions does trial NCT04998019 study?
This clinical trial studies the following conditions: HIV/AIDS.
What interventions are being tested in trial NCT04998019?
The interventions under investigation include: PositiveLinks (BEHAVIORAL).
Who is sponsoring clinical trial NCT04998019?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04998019 being conducted?
This trial has 13 study locations across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV/AIDS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04998019's enrollment target sits among peer trials
682 7th of 61 higher than 55 of 61 other HIV/AIDS trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV/AIDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence
RECRUITING · NA
-
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
RECRUITING · NA
-
MyPEEPS LITE Trial
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Improving the Organizational Social Context to Address Structural Racism and Discrimination
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05382559 · 681 participants · Phase 1
A Study of ASP3082 in Adults With Advanced Solid Tumors
- NCT06795087 · 684 participants
Discharge Medication Use Post-Operatively in GU Cancer Patients
- NCT03501706 · 680 participants · NA
An Assessment of Cognitive Improvement Training Among Mid-life Individuals
- NCT05626452 · 680 participants · NA
PrEP Optimization Among Women to Enhance Retention and Uptake
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI